Randomized Phase II Trial Comparing Two Dose Levels of Thymoglobulin in Patients Undergoing Unrelated Donor Hematopoietic Cell Transplant

Leukemia and Lymphoma - United Kingdom
doi 10.3109/10428194.2011.634039
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Phase II Clinical Trial of Etanercept Plus Extracorporeal Photopheresis GVHD Prophylaxis Following Unrelated Donor Reduced Intensity Transplant

Biology of Blood and Marrow Transplantation
TransplantationHematology
2015English

No Association Between Donor Telomere Length and Outcomes After Allogeneic Unrelated Hematopoietic Cell Transplant in Patients With Acute Leukemia

Bone Marrow Transplantation
TransplantationHematology
2017English

Treatment of Fanconi Anemia Patients Using Fludarabine and Low-Dose TBI, Followed by Unrelated Donor Hematopoietic Cell Transplantation

Bone Marrow Transplantation
TransplantationHematology
2010English

Donor Lymphocyte Experience in Pediatric Allogeneic Hematopoietic Stem Cell Transplant Patients

Biology of Blood and Marrow Transplantation
TransplantationHematology
2018English

Outcomes From Unrelated Donor Hematopoietic Stem Cell Transplantation

Cancer Control
MedicineOncologyHematology
2011English

Clofarabine-Associated Acute Kidney Injury in Patients Undergoing Hematopoietic Stem Cell Transplant

Leukemia and Lymphoma
Cancer ResearchOncologyHematology
2014English

Impact of Donor Characteristics and HLA Matching on Survival of Chinese Patients With Hematologic Malignancies Undergoing Unrelated Hematopoietic Stem Cell Transplantation

Biology of Blood and Marrow Transplantation
TransplantationHematology
2012English

Successful Second Unrelated Donor Hematopoietic Stem Cell Transplant in a Patient With Dyskeratosis Congenital After First Graft Rejection

Experimental and Clinical Transplantation
Transplantation
2017English

Impact of Anti- T Lymphocyte Globulin (ATLG) on Immune Reconstitution in Patients Undergoing HLA Matched Unrelated Myeloablative Hematopoietic Cell Transplantation (HCT): Results From a Prospective Randomized Double Blind Phase 3 Clinical Trial

Biology of Blood and Marrow Transplantation
TransplantationHematology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy